CD2 subserves both adhesion and signal transduction functions in T cells, thymocytes, and natural killer (NK) cells. In mature T lymphocytes, CD2-mediated signaling function apparently requires surface expression of T cell receptors (TCRs). In contrast, in CD2+CD3 -NK cells and thymocytes, signal transduction through CD2 is TCR independent . To resolve this paradox and characterize TCR-independent triggering mechanisms, we transfected a human CD2 cDNA into a murine mast cell line, C1.MC/57 (Fcc-Rl+, FcyRII+, FcyRIII+), which is known to produce interleukin 6 (IL6) as well as release histamine in response to crosslinking of FceRI. In the CD2 transfectant, a combination of antiT112 + antiT113 monoclonal antibodies (mAbs) induced a rise in intracellular free calcium ([Ca2 +]i), 11,6 production, and histamine release . As expected, no activation was mediated by the same mAbs in C1.MC/57 . F(ab)'2 fragments of the activatory combination of antiT112 + antiT113 mAbs induced IL-6 in the CD2-transfected mast cells, demonstrating an Fcy receptor ectodomain-independent triggering mechanism . In addition, either intact anti-T112 or anti-T113 IgG alone, which failed to induce [Ca 2 +]i mobilization in the transfectant, was able to induce IL6 production . A mAb directed against both FcyRII (previously denoted as Fc-yRIIb) and FcyRIII (previously denoted as FcTRIIa) inhibits this induction . These results indicate that: (a) Cat+ mobilization is not essential for IL6 production ; and (b) crosslinking of CD2 and Fcy receptors via intact anti-CD2 IgG stimulates 11,6 production . Thus, CD2-mediated IL6 production occurs by both Fc receptor ectodomain-independent as well as Fc receptor ectodomain-dependent mechanisms in these nonlymphoid cells . Northern blot analysis demonstrates that although the mast cells do not express CD31' or CD3vl mRNA, they express Fcc-RIy mRNA. The latter is a known component of FcyRIII as well as FceRI, has significant homology to CD31'/t, and is thought to have a signal transduction function. In these mast cells, CD2 signaling machinery does not require CD31'/rl and may be linked to the Fcc-RIy subunit . We predict that this subunit or a related structure may confer a TCR-independent signal transduction pathway upon CD2 in CD3 -NK cells, thymocytes, and certain B lymphocytes . T he CD2 (T11 structure) has been shown to play an important role in the function of both thymus-derived T cells and NK cells (1, 2). mAbs directed against an epitope (T11i) within the NH2-terminal adhesion domain of CD2 block the ability of T cells (3-5), thymocytes (6), and NK cells (4) to interact with the LFA-3-expressing cognate partners. Predictably, therefore, helper and cytotoxic T cell responses, thymocyte-epithelial conjugate formation, and lytic efFector function of NK cells are reduced or eliminated by such mAbs. Also, the adhesion function ofCD2 molecule has been shown to directly contribute to the T cell recognition of nominal antigen (7, 8) . In addition to the adhesion function ofCD2, mAbs directed at a second adhesion domain epitope (T112), in concert with a mAb specific for an epitope (T113) within the membrane proximal domain, activate T lymphocytes (3, 4), thymocytes (9), and NK cells (4) . Moreover, the cellular CD2 ligand LFA-3 itself, in conjunction with antiT113 mAb, can activate T cell responses (10). Collectively, these findings indicate an important role for CD2, not only in functioning as an adhesion structure, but also as an activation receptor.
T he CD2 (T11 structure) has been shown to play an important role in the function of both thymus-derived T cells and NK cells (1, 2) . mAbs directed against an epitope (T11i) within the NH2-terminal adhesion domain of CD2 block the ability of T cells (3) (4) (5) , thymocytes (6) , and NK cells (4) to interact with the LFA-3-expressing cognate partners. Predictably, therefore, helper and cytotoxic T cell responses, thymocyte-epithelial conjugate formation, and lytic efFector function of NK cells are reduced or eliminated by such mAbs. Also, the adhesion function ofCD2 molecule has been shown to directly contribute to the T cell recognition of nominal antigen (7, 8) . In addition to the adhesion function ofCD2, mAbs directed at a second adhesion domain epitope (T112), in concert with a mAb specific for an epitope (T113) within the membrane proximal domain, activate T lymphocytes (3, 4) , thymocytes (9) , and NK cells (4) . Moreover, the cellular CD2 ligand LFA-3 itself, in conjunction with antiT113 mAb, can activate T cell responses (10) . Collectively, these findings indicate an important role for CD2, not only in functioning as an adhesion structure, but also as an activation receptor.
The signal transduction function of CD2 is dependent on its CD2 cytoplasmic tail (11) (12) (13) . Truncation analysis and sitedirected mutagenesis have pinpointed a region between amino acid residues 253 and 287 that is necessary for IL-2 gene induction and increase in intracellular free calcium ([Ca 2 +],)t (11) . Disruption of a single histidine and arginine at positions 264 and 265 within the first of two tandem PPPGHR repeat sequences can abrogate or dramatically reduce T cell activation (14) . The activation of T lineage cells via CD2 is also dependent on other cellular structures. In this respect, studies conducted on a TCR -variant of the human T cell tumor line Jurkat lacking Ti /3 transcripts showed that such cells could not be stimulated via CD2 (15) . Reconstitution of TCR surface expression in these Jurkat mutants by Ti a gene transfection restored CD2 triggering function . These findings directly demonstrate that the CD2-mediated signal transduction pathway is dependent on the expression of TCR and that both TCR and CD2 activation pathways in T cells are interconnected. Two indirect lines of evidence also support this notion in T lymphocytes. First, prior crosslinking of TCR inhibits subsequent CD2-mediated activation (16) (17) (18) . Second, submitogenic concentrations of antiTCR mAbs and anti-CD2 mAbs, which independently fail to activate T cells, in combination induce T cell proliferation (19) . The importance of TCR expression for CD2 signal transduction function has been further emphasized by the failure of CD2 to trigger activation events when transfected and expressed in SF9 (Spodoptera frugiperda) worm gut epithelial cells (20) or murine fibroblasts (21) .
Despite the dependence ofCD2 function on surface TCR expression in T lymphocytes, both thymocytes and NK cells that lack surface TCR can be triggered upon CD2 stimulation to increase [Ca 2
and mediate cytotoxic activity, respectively (4, 9) . The basis of this seemingly paradoxical TCRindependent CD2 signal transduction function is unknown, although we have speculated that it may result from the coupling of CD2 to other transduction elements in NK cells (1) . A likely candidate that might functionally interact with the CD2 pathway in these CD2 'CD3 -NK cells is FcyRIII (CD16). CD16 has recently been shown to be physically associated with CD3 f (22, 23) and is also thought to associate with the y subunit of FceRI (FceRIy) (24) . The latter is a component of the tetrameric high affinity IgE receptor expressed on mast cells and basophils (25) , whose broader tissue distribution is only now becoming apparent (26) . Interestingly, CD3(' and FceRI-y belong to the same gene family located on murine chromosome 1 and are homologous at the primary sequence level (27, 28) . Thus, TCR independent CD2 signal transduction might be linked to either C133f or Fcc-RIy or both.
To investigate these possibilities, we transfected a human CD2 cDNA into murine mast cells that express FcERIy as a component of their FceRI as well as FcyRIII (previously denoted as FcyRIIa in mouse) and examined the ability of CD2 to trigger [Ca 2 +1, increase and IIr6 production . The results demonstrate that CD2 is competent to transduce signals in mast cells, hence proving that TCR expression and/or lymphoid phenotype is not required for CD2 function . Moreover, because the mast cell line lacks both CD3 f and CD3,q mRNA, neither CD3(' nor CD3vl is required for CD2 signaling.
Materials and Methods
Cell Lines and Transfection of Human CD2. A~o-2 helper-free retrovirus packing cell line, which has been transfected with the expression vector DOL carrying both the neomycin resistance gene and a cDNA of human CD2, was used to generate virus stocks for the infection of mast cells (11) . A growth factor-independent mast cell line, C1.MC/57 (denoted as MC/57 in the text below),
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CD 2 Function in FcR+ Cells derived from C57BL/6J mouse bone marrow was a kind gift from S. Galli (Beth Israel Hospital, Boston, MA) (29) . MC/57 mast cells were maintained in DME (Whittaker MA Bioproducts, Walkersville, MD) supplemented with 10% heat-inactivated FCS (Sigma Chemical Co., St. Louis, MO), 5 x 10 -s M 2-ME (Sigma Chemical Co.), 2 MM L-glutamine, and 1% penicillin-streptomycin (Gibco Laboratories, Grand Island, NY) . Procedures for the growth of9-2 cells, harvesting of virus, and infection of MC/57 mast cells were performed as described (11) . The MC/57 mast cell line was infected with freshly derived virus stocks in the presence of 8 ug/ml polybrene (Aldrich Chemical Co., Milwaukee, WI), and selection was initiated 48 h later in 2 mg/ml of G418 (geneticin; Gibco Laboratories) . The G418-resistant colonies were screened by indirect immunofluorescence as described below. Additional cell lines used in this study, 2B4.11 and MA5.8, were provided byJ.D. Ashwell (NIH, Bethesda, MD), and MH60.BSF2 was a gift from T Hirano and T. Kishimoto (Institute for Molecular & Cellular Biology, Osaka University, Osaka, Japan) (30) . Flow Cytometric Analysis. Phenotypic analyses were performed using indirect immunofluorescence assays . 10' cells were analyzed in each sample on an Epics V cell sorter, and results were expressed as histograms displaying number ofcells vs. fluorescence intensity on a log scale. A 1:400 dilution ofascites containing IgE anti-DNP mAbs (31) (Hl-DNP-E-26, provided by S. Galli), a 1:200 dilution of ascites containing either anti-T11, (3Pt2H9, IgGl) (3), anti-T11 2 (1old24C1, IgG2a) (3), or anti-T113 (lmono2A6, IgG3) (3) mAbs, and culture supernatant containing monoclonal anti-H-2Db (AF6-88.5.3, IgG2a, kindly provided by K. Rock, Dana-Farber Cancer Institute) (32) were used in this study. Saturating amounts of an anticlonotypic mAb, 11C5 (IgG1 derived in our lab ; 1:200 dilution of ascites), was used as a control to subtract background Fey receptor binding. Cells incubated with the above mAbs for 30 min at 4°C were washed with HBSS containing 2% FCS. The antibody bound was detected with a 1:40 dilution of fluorescein-conjugated goat anti-mouse IgG (H + L) second antibody (Whittaker MA Bioproducts) by using the Epics V cell sorter. CD2 transfectants were sorted for higher levels ofCD2 expression on the Epics V cell sorter by staining up to 5 x 106 cells as described above.
Determination of Cytosolic;free Ca 2' by Indo-1 Fluorescence [Ca2']; was determined according to Grynkiewicz et al. (33) . Briefly, 2 x 106 cells were suspended in 200 pl of DMEM containing 10% FCS and 2 F6g/ml acetoxymethylester of Indo-1 (Molecular Probes, Junction City, OR) for 30 min at 37°C. Cells were then diluted up to 1 ml with DME containing 10% FCS and kept at 37°C before analysis on the Epics V cell sorter. For determination of triggering through FceRI, cells were incubated with a 1:400 dilution of ascites containing IgE anti-DNP mAb for 30 min at room temperature and washed twice as described above before loading with Indo-1 . The ratio of Indo-1 fluorescence at 410 nm to that at 480 nm was recorded in real time and expressed in arbitrary units, each of which represents -200 nM [Ca 2'];. Samples were analyzed at room temperature by running the Indo-l-loaded cells on the Epics V cell sorter for 1 min to establish a baseline before adding the following stimuli : 100 ng/ml DNP-BSA (Sigma Chemical Co.), a 1:100 dilution of antiT112 + antiT113, or a 1:100 dilution of antiT112 + control mAb (anti T8, 1mono2E7, an IgG3 isotypematched mAb for anti-T113) . Cells that did not show [Ca 2+ ); mobilization received 1 hg/ml ofcalcium ionophore A23187 (Sigma Chemical Co.). All concentrations indicated above are final concentrations of the respective stimuli . 11, 6 Production Assays . Quantitation of 11,6 secreted into the culture supernatant after stimulation of mast cells was analyzed by bioassay. 106 mast cells were plated in 24-well plates and incubated at 37°C, 5% C02, for 24 h with the following panel of stimuli: antiT112 + antiT113, antiT112 + control IgG3 (antiT8, 1mono2E7, a control irrelevant isotype-matched mAb for anti-T113), antiT112, anti T113, control IgG2a (anti-T1, 24T6G12, a control irrelevant isotype-matched mAb for anti-T112), control IgG3, DNP-BSA, PMA, and media. All of the above-mentioned antibodies were protein A purified and incubated at a final concentration of 10 jig/ml . DNP-BSA and PMA were used at a final concentration of 100 ng/ml. Mast cells that were triggered through Fcc-RI were incubated with IgE anti-DNP mAb for 30 min at room temperature and washed twice as described above before stimulation with DNP-BSA. For studies conducted on CD2 activation after Fcy receptor blockade, a mAb, 2AG2, that recognizes both mouse FcyRII and FcyRIII (34) (kindly provided by J.-P. Kinet, NIH) was used at 5 hg/ml either alone or in the presence of anti-T112 mAb. In other experiments, antiT112 mAb stimulation was tested in the presence of 10-100 Ftg/ml of control IgG2a isotypematched mAb. Supernatants harvested after 24 h were titrated in triplicate in serial fivefold dilutions for their ability to support the growth of an U,6-dependent murine hybridoma clone MH60.BSF2 (30) . Simultaneously, triplicates of twofold serial dilutions of rIL6 (a kind gift of Ajinomoto Co . Inc., Tokyo, Japan) were prepared . MH60 .BSF2 cells cultured in RPMI containing 10% FCS and 200 pg/ml rIL6 were washed and then cultured for 6 h before the assay in the absence of 11,6 . Subsequently, 104 MH60 .BSF2 cells were added to each well of 96-well plates (fiat-bottomed) containing either dilutions of samples or rIL6 and cultured for 44 h at 37°C, 5% C0 2, and pulsed with 1 pCi/well [3H]thymidine (ICN Biomedicals Inc., Irvine, CA) during the last 7 h of incubation . The cells were harvested on glass fiber filter papers and incorporation of ['H]thymidine was determined by a liquid scintillation counter. Results are expressed as rIL6 equivalent (ng/ml/106 cells) production as determined from the standard titration curve of rIL6 in triplicate samples.
Generation of F(ab)'2 Fragments. F(ab)'2 fragments for anti-T112 and antiT113 mAbs were produced using the Immunopure F(ab)'2 preparation kit as recommendedby the manufacturer (Pierce Chemical Co ., Rockford, IL). 2 mg of protein A-purified anti T11 mAbs (6 mg/ml) that were dialyzed against 20 mM sodium acetate buffer, pH 4.5 were incubated with 450 pl of the appropriate digestion buffer containing 150 p,l of immobilized pepsin in a shaker water bath at 37°C. The anti-T112 (IgG2a) and anti-T113 (IgG3) mAbs were digested for either 60 min in digestion buffer, pH 4.1, or for 15 min in digestion buffer, pH 4.3, respectively. The digested F(ab)'2, Fc fragments and undigested IgG were recovered from immobilized pepsin and, subsequently, the Fc fragments and undigested IgG were depleted on a protein A column as outlined in the protocol for the kit. Briefly, each anti-T112 and anti-T113 crude digest was added to separate immobilized protein A columns equilibrated with binding buffer and incubated for 1 h. Thereafter, the columns were washed with binding buffer and the flow through fractions containing the F(ab)'2 fragments were collected and dialyzed against PBS, pH 7.4, in dialysis tubing with a molecular weight cut off of 50,000 to remove any small Fc fragments that did not bind protein A. The purity of the protein A-purified F(ab)'2 fragments was checked by nonreducing and reducing SDS-PAGE using Coomassie G-250 staining and was >95% .
Histamine Release. Histamine release into culture supernatants after stimulation of mast cells was analyzed using the histamine radioimmunoassay kit (Amac Inc., Westbrook, ME). 106 mast cells were stimulated for 10 and 60 min with either anti-T11 2 + anti-T113, antiT112, or DNP-BSA. Mast cells triggered with DNP-BSA were incubated with monoclonal IgE anti-DNP-BSA and 86 1
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washed as described above before stimulation. Histamine released in culture supernatants after activation was analyzed according to the manufacturer's recommendations. Briefly, 100 pl of samples or histamine standards was added to acylation tubes containing acylatiog agent. The acylated histamine was subsequently added into tubes coated with mAb to acylated histamine in the presence of "1I-labeled acylated histamine. After incubation for 18 h at 4°C, tubes were emptied and counted for 1 min in a gamma counter. Results are expressed as nM histamine per 106 cells/ml by comparison of the radioactivity bound to a standard curve run in parallel.
Northern Blot Analysis. Total RNA was isolated from cell lines using guanidineisothiocyanate (35) . RNA concentrations were measured spectrophotometrically and 10,ug of total RNA was run per lane on a 1% agarose gel containing 2.2 M formaldehyde and 1x MOPS buffer (35) . The RNA was then transferred to nitrocellulose in 20 x SSC and the RNA blot hybridized to a CD3rt-specific probe containing the 3' AvaII/EcoRI fragment of pBS17 (36) . Hybridization was carried out in a solution containing 50% formamide, 5x SSC, 5 x Denhardt's, 250 Ag/mldenatured salmon sperm DNA, 50 mM NaHP04, pH 6.5, at 42°C for 16-20 h with 106 cpm/ml probe. Subsequently, the blot was washed in 2x SSC, 0.1% SDS for 15-30 min at room temperature and 0.1 x SSC, 0.1% SDS at 50°C for 30 min, and was exposed to Kodak X Omat AR X-ray film at -70°C for the indicated time. The blot was then stripped by boiling in distilled water for 10 min and exposed for 12-14 h to insure that all signals had been removed. The filter was then hybridized to the CD3~-specific probe containing the 3' EcoNI/ EcoRl fragment of pBS23 (37) using conditions as described for the CD3rt-specific probe, washed, and autoradiographed . After stripping once again, theblot was hybridized to the rat Fcc-RI-y-specific cDNA probe containing the 3' BamHI/Xbal fragment (25) using the same conditions described above.
Results

Generation of Human CD2-expressing Murine Mast Cell
Lines . To generate CD2 surface expression in mast cells, MC/57 cells were infected with the defective retrovirus vector DOL, which bears the human CD2 cDNA and neomycinresistant gene (11) , and subsequently, a stable mast cell transfectant was selected by flow cytometry as described in Materials and Methods. As shown in Fig. 1 , whereas the parental mast cell line, MC/57, does not show any detectable level of human CD2 expression (Fig. 1 a) , the human CD2 transfectant C1 .MC/57/64.1(denoted as MC/64.1 in the text below) expresses surface CD2 as judged by its reactivity with mAbs to the distinct CD2 epitopes T11t, T112, and T113 (Fig. 1   df) . The level of CD2 expressed in these cells is comparable with that of the endogenous H-2Db molecules (Fig. 1, c and  h ) . Both the parental and CD2-transfected mast cell lines express equivalent levels of Fcc-Rl (Fig. 1, b and g ) . These cells also express equivalent levels of both FcyRII (previously denoted as Fc-yRIIb) and FcyRIII (previously denoted as Fc-yRIIa) (data not shown) . Neither MC/57 nor MC/64.1 express TCR as judged by indirect immunofluorescence staining with antimurine CD3e mAb, 145.2C11 (data not shown) .
Human CD2-mediated (Ca 2 +J Changes in CD2-transferred Mast Cells. Next, the ability of CD2 to trigger a rise in [Ca2+]i in the MC/64.1 mast cell transfectant was examined. The amount of IL-6 present in culture supernatants was assessed from the titration of culture supernatants and rIL-6, as shown in Fig. 3 , and is expressed in rIL-6 equivalents. Control IgG2a is a control mAb isotype matched for anti-T112. Control IgG3 is a control mAb isotype matched for anti-T113. SD of IL-6 concentrations were <20% . Results are representative of more than six experiments .
a functional signal transduction machinery in both cell types (38) . In contrast, as shown in Fig. 2 (Fig . 2 e) . Nevertheless, the MC/64.1 cells were efficiently loaded with Indo-1 as judged by the ability of the calcium ionophore A23187 to increase [Ca 2+]i (Fig. 2 e, arrowhead) . These findings indicate that both T112 and T113 epitopes on the MC/64.1 mast cells need to be ligated by antibody in order to increase [Ca2+]i mediated through CD2. Hence, these data are consistent with earlier studies in T cells, thymocytes, and NK cells, demonstrating that the addition of both antiT112 + anti-T113 mAbs triggers a [Ca2
flux (3) (4) (5) 9) . Induction of11,6 Production in CD2-turns.fected Mast Cells with Anti-CD2 mAbs. Stimulation of bone marrow-derived mast cell lines including MC/57 through their FceRI was previously shown to result in induction of a number of cytokine genes including 1176 (38) . To determine whether stimulation of CD2 would result in IL6 production from the MC/64.1 transfectant, culture supernatants from either the parental MC/57 or MC/64.1 lines treated with various stimuli were assayed for IL6 activity. For comparison, IL-6 production stimulated via FceRI was examined in parallel. As expected, the stimulation of both MC/57 and MC/64.1 lines through their FceRI receptors with a combination of anti-DNP-IgE and DNP-BSA resulted in production of IL6 (Table 1, Fig.  3 ). More importantly, the CD2-transfected MC/64 .1 mast cell line produced 11,6 when stimulated with a combination of anti-T112 + antiT113 mAbs. In contrast, treatment of the same cells with media or the parental MC/57 mast cells with antiT112 + anti-T113 mAbs failed to induce IL-6 production ( Fig. 3 , Table 1 ). In fact, the amount of IL-6 produced by CD2 stimulation was greater than that after FceRI stimulation in MC/64.1 cells by a factor of 20. Thus, signalling through CD2 with antiT112 + antiT113 mAbs in MC/64.1 mast cells results in both an increase in [Ca 2 +]i and 11,6 production. Somewhat unexpectedly, we observed that stimulation of MC/64.1 mast cells with either antiT112 or antiT113 mAbs alone also generated significant IL6 production. As shown in Table 1 , MC/64.1 mast cells stimulated with a combination of antiT112 + control IgG3 (an irrelevant mAb isotype matched to antiT113 mAb) produced a substantial quantity of IL-6 relative to MC/64.1 cells stimulated with media or parental MC/57 cells stimulated with a combination of anti-T112 + anti-T113 mAbs (1,200 ng/ml/106 cells vs. 0.1-1.8 ng/ml/106 cells) . Similarly, as shown in Table 1 (Exp. 1), the stimulation of MC/64.1 mast cells with anti-T112 mAb alone induced the production of 11,6 comparable in magnitude with the amount produced by the combination of antiT112 + antiT113 (1,500 vs. 2,300 ng/ml/106 cells) . Likewise, the antiT113 mAb by itself was capable of inducing MC/64.1 cells to produce 11, 6 . Note that the stimulation of MC/64.1 mast cells with either control IgG2a or 863 Arulanandam et al .
control IgG3 mAbs resulted in little or no IL6 production . Thus, in the MC/64.1 mast cells, crosslinking ofmore than one T11 epitope on CD2 is not an absolute requirement for the generation of signals leading to production of IL6. In this context, it is known that mast cells express Fcy receptors including FcyRII (39) to which the above mAbs could bind. To investigate Fcy receptor ectodomain-independent signal transduction via CD2, anti-T112 and antiT113 F(ab)'2 fragments were produced and MC/64.1 cells were cultured with a combination of antiT112 F(ab)'2 + anti-T113 F(ab)'2 . As shown in Table 2 , this stimulation resulted in production of 11,6 (2,100-3,100 ng/ml/106 cells), comparable with that observed with intact antiT112 + antiT113 IgG (Table 1 ). This result indicates that MC/64 .1 cells can be activated with a combination of antiT11 mAbs independent of Fcy receptor ectodomain binding. Table 2 also shows that reduced but clearly significant IL6 production was triggered by addition of antiT11 3 F(ab)'2 alone and, to a lesser extent, by antiT112 F(ab)'2 . The amount of IL-6 induced with either one of the antiT11 F(ab)'2 fragments (Table 2) was significantly less than the amount of IL6 produced with any single intact antiT11 mAb (Table 1) . Thus, the binding of intact antiT11 mAbs to FcyRII or FcyRII as well as to CD2 in MC/64.1 cells apparently enhances induction of1176. In contrast, a mouse anti-H-2Db mAb, which is of the same IgG2a isotype as anti-T112, failed to induce any 11,6 production in MC/64.1 ( Table 1 ), indicating that the mere binding of antibody to both H-2Db and Fcy receptor molecules is not sufficient to trigger IL-6 production.
To more definitively examine the role of the Fcy receptor in CD2-mediated IL6 production, two types of blocking studies were performed. In the first experiment, mAb 2.4G2, which recognizes both FcyRII and FcyRII (34) , was added to the culture along with anti-T112 mAb. As shown in Table  3 , 2AG2 addition markedly reduced antiT112-induced 11,6 production and was itself without any activatory effect. In a separate experiment, isotype-matched IgG2a control mAb used in 10-fold excess of antiT11 2 mAb completely blocked 11,6 induction . Taken together, these findings show that the 
CD2 Couples to the Histamine Release Pathway in Mast Cell
Transfectants. Stimulation ofmast cells via the FceRI receptor is known to induce histamine release. To determine whether CD2 stimulation couples to the histamine release pathway, MC/57.1 and MC/64.1 were stimulated with anti-T112 + antiT113 mAbs or antiT112 alone for 1 h and supernatants examined for histamine content by RIA . As shown in Table  4 , a combination of antiT112 + antiT113 or antiT112 alone showed stimulation to the same degree as stimulation by crosslinking of FceRI by IgE/DNP-BSA in MC/64 .1 . Similar results were obtained when MC/64.1 was examined after 10 min of stimulation (data not shown) . Note that, as expected, anti-CD2 mAbs had no effect on MC/57.1 . These results in conjunction with the above studies demonstrate that CD2 couples to both 11,6 and histamine release pathways in mast cells.
Mast Cell Line MC/S7 Does not Express CD3~or CD3rl.
Recent biochemical analysis of human FcyRIII (CD16) on human NK cells reveals that CD16 is associated with the TCR CD3~subunit (22, 23) . In addition, it is thought that the FceRly, which is homologous to CD3~, associates with CD16 in human NK cells (24) , and FcyRIII in murine macrophages and mast cells (26) . We thus examined if murine mast cells expressing FceRI and FcyRIII also express CD3~or the related CD3r1, since one or both might be involved in CD2-mediated signal transduction in the MC/64.1 mast cell line. To this end, Northern blot analysis was performed using specific cDNA probes for CD3~, CD3q, and FcERIy, with RNA from the MC/57 parental mast cell line, a murine T cell hy-
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CD2 Function in FcR' Cells CD3rl (37) . As shown in Fig . 4 , MC/57, like MA5 .8, lacks transcripts corresponding to CD3~and CD3,q. In contrast, and as expected, 2114.11 contains transcripts of 2 .0 and 1 .8 kb, which correspond to CD3~and CD3n, respectively (Fig.  4, b and c) . On the other hand, MC/57 mast cells but not 2114.11 or MA5 .8 express a transcript of -0.5 kb, which corresponds to the mRNA of Fcc-kly (Fig. 4 a) . These results indicate that the MC/57 mast cell line can transmit signals via the transfected CD2 gene product in the absence of CD3õ r CD3,q. Northern blot analysis of CD3~, CD3rt, and FeER-y subunit gene expression in MC/57 mast cells (C57) . 10 Ag of total RNA isolated from the indicated cells was size fractionated on a 1% agarose gel containing formaldehyde and transferred to nitrocellulose. Subsequently, the filter was hybridized with a CD3q-specific probe, washed, and exposed at -70°C for 1.5 d with an intensifying screen (c) . The filter was then stripped, reprobed with a CD3I'-specific probe, and exposed for 4 d (b) . After stripping once more, the filter was hybridized with a probe for the FcERIy subunit and exposed for 2 . In an effort to better understand the nature of TCRindependent CD2 signal transduction, we performed CD2 transduction studies using mast cells as recipients . The latter were chosen based on the premise that Fc receptors might function in lieu of the TCR for transduction coupling to CD2 in some cells and to determine whether CD2 signal transduction might be operative in nonlymphoid cells. The present study provides new insight into both the signal transduction mechanism of CD2 and the pathway ofIL6 production and histamine release. Our results indicate that when human CD2 is expressed in mast cells, perturbation of the extracellular segment with a combination of antiT112 + anti-T113 mAb leads to an increase in [Ca 2+];, IL6 production, and histamine release. IL6 production can be mediated independently of the extracellular segment of Fcy receptor since F(ab)' 2 fragments of these same mAbs induced IL6 production comparable with that obtained with intact mAbs. In addition, we observed that crosslinking of the CD2 with Fcy receptor using a single antiT112 or antiT113 mAb could also stimulate IL6 production. Under these latter circumstances, the crosslinking apparently results from the Fe portion ofthe mAb binding to Fcy receptor and the antigen-binding sites of the same mAb ligating to CD2, thereby approximating CD2 and FCy receptor structures.
Cytokine gene activation studies conducted on parental MC/57 mast cells by Burd et al. (38) with a panel of activating agents showed that the 11,6 gene activation can be induced independently of FceRl. Activation by PMA or Con A, as well as through FceRI, resulted in the induction of IL-6 mRNA as detected by Northern blot analysis. Interestingly, the calcium ionophore A23187 did not induce the IL-6 gene in these MC/57 cells, whereas translocation of protein kinase C by itself was sufficient for IL6 gene induction, indicating that Ca2+ mobilization is not essential for 11,6 induction. In contrast to the failure of calcium ionophore to induce the IL6 gene, it has been shown that a calcium ionophore is itself sufficient to mimic IgE-dependent histamine release in mast cells (40) . These findings indicate that histamine release and IL-6 production utilize different signal transduction mechanisms in mast cells.
Additional evidence for a calcium-independent mechanism for IL-6 production was obtained from the present study. A single ant-T112 mAb that failed to induce Ca2+ mobilization in MC/64.1 cells was capable of inducing 1176 in these same cells. On the other hand, the combination of antiT112 + antiT113 mAbs induces Ca2+ mobilization and IL6. These results clearly indicate that 11,6 production is induced either in the presence or absence of Ca2+ mobilization. Although activation through CD2 produced less Ca2+ mobilization relative to activation via FceRI (Fig. 2 d compared  with 2, a and c) , the amount of IL-6 produced upon CD2 stimulation was significantly higher than IL-6 produced after activation through FceRI ( Table 1 ). The dichotomy observed between Ca 2+ mobilization and IL-6 induction through CD2 and FceRI may be explicable if several transduction pathways operate in parallel in the mast cell. It is likely that 86 5 Arulanandam et al .
a Cat+-independent pathway plays a significant role in the induction of IL6 after activation via either CD2 or FceRI . This pathway may include a Cat+-independent activation of protein tyrosine kinase (PTK), which has already been demonstrated in rat basophilic leukemia cells upon triggering through FceRI (41) . It is thus possible that the MC/64.1, mast cells may utilize a PTK pathway for IL6 induction. Interestingly, it was shown that tyrosine phosphorylation (in the absence of extracellular calcium) is not sufficient to induce histamine release and required the presence of calcium in the extracellular media. This finding is consistent with the fact that calcium mobilization in mast cells can lead to histamine release (40) . However, the ability of anti-T112 mAb to trigger histamine release (Table 4 ) without a detectable increase in [Ca 2+]; (Fig. 2) implies an additional complexity to the process of histamine release.
Our observations that an activatory combination of anti-T112 + anti-T113 mAbs causes calcium mobilization, production of IL6, and histamine release on human CD2-transfected MC/64 .1 mast cells in the absence of TCR expression ( Fig. 2 d and Table 1 ) is somewhat analogous to the situation in CD3 -thymocytes. Previous studies with thymocytes have shown that the same combination of anti-T112 + anti-T113 mAbs causes a mobilization of [Ca 2 +]i and I1r2R expression (9, 9a) . Although the activation requirements for IL2R expression and IL6 induction are not directly comparable, TCR independent human CD2 signal transduction in MC/64.1 cells and thymocytes results in both an early change in the ionic milieu of the cell and activation of gene programs . Moreover, the observation that a single anti-T112 antibody is incapable ofmobilizing [Ca 211, in these MC/64 .1 mast cells (Fig. 2, e) is consistent with the activatory requirements of TCRindependent signaling in CD3 -thymocytes (9) .
The TCR-independent human CD2 signal transduction obtained with MC/64 .1 cells is also reminiscent of the activation requirements in CD2+CD3 -NK cells . Anti-T112 + antiT113 mAbs activate NK cells to lyse their target (4) . Moreover, F(ab)'2 fragments of anti-T112 + anti-T113 mAbs, which activate MC/64.1 cells to produce IL6 (Table 2) , have also been shown to activate NK cells to lyse target (42) . Thus, an Fcy receptor ectodomain-independent mechanism ofhuman CD2 signal transduction is operative in both MC/64.1 cells and NK cells . On the other hand, it should be noted that human NK cells express FcyRIII (CD16), and single anti-CD2 mAbs activate NK cells in the same way that a single anti-CD2 mAb can induce IL-6 production in MC/64.1 cells. For example, in one report, a single anti-CD2 mAb CLB-T11 was shown to induce cytolysic activity of CD3 -CD16+ NK cells (5) . In a second independent study, Annasetti et al. (43) showed that the addition of an anti-CD2 mAb 9.1 but not its F(ab)'2 fragment to CD3 -CD16+ NK cell lines resulted in cytolysis oftargets. The observation of Fcy receptor ectodomain dependency in NK cell activation is consistent with our observation in mast cells that F(ab)'2 fragments of either antiT112 or antiT113 mAbs were not as efficient as a single intact antiT112 or antiT113 mAb in inducing IL-6 production in MC/64 .1 cells (Tables 1 and 2 ). Perhaps more importantly, a mAb that recognizes both FcyRII and FcyRIII or excess control IgG2a isotype-matched mAb blocks anti-CD2-mediated activation ofIIr6 production by a single anti-CD2 mAb in CD2-transfected mast cells. Hence, it is likely that the ectodomain of FcyRIII, the murine homologue of human CD16 (44, 45) , is involved in CD2 signal transduction when a single anti-CD2 mAb binds to CD2 in both mouse MC/64.1 and human NK cells. Crosslinking of H-2Db molecules to Fcy receptor failed to stimulate any significant amount of IIr6 (Table 1) . Therefore, crosslinking of Fcy receptors to other unrelated molecules is not necessarily capable ofinducing activation. These results collectively indicate that activation pathways involving Fcy receptor ectodomain-dependent and -independent mechanisms operate in TCR-independent activation through CD2 .
Other studies have shown that Fc receptors on both mast cells and NK cells function as signal transduction molecules . Crosslinking of CD16 molecules (FcyRIII) by certain anti-CD16 mAbs activate human NK cells (46) . Similarly, crosslinking of the FceRI on both the parental MC/57 and human CD2 transfected MC/64.1 cells with a combination of IgE anti-DNP mAb and DNP-BSA resulted in mobilization of [Ca 2+]i and IIr6 production (Fig. 2 , a and c, and Table 1 ) (38) . With respect to the structure of the FceRI and FcyRIII expressed on mast cells, it is known that they both share a common y subunit, FceRIy (26) . FceRIy has been shown to have substantial homology with CD3 subunits ofthe TCR including CD3 ' and CD37I subunits (36, 47, 48) . Recent studies on human NK cells have revealed that the CD3' subunit is associated with CD16 in the absence of the other TCR subunits (22, 23, 49) . In addition, studies conducted on the expression of CD16 suggested that FceRIy is associated with CD16 (24) . Given the fact that there is evidence suggesting that the C132-mediated activation of NK cells requires the coexpression ofCD16 (46) , it is possible that CD2 functionally couples to either the CD3' or FceRIy subunit or both. Our findings by Northern analysis that the CD2-transfected MC/64.1 mast cells do not express any CD3' or related CD3r7 indicate that these subunits are not essential for CD2 signalling (Fig. 4) . In view of the aforementioned expression data, it is tempting to speculate that the FceRIy subunit is a structure involved in the functional coupling of CD2 and FcyRIII on MC/64.1 cells .
In addition to NK cells and thymocytes, murine B cells express CD2 in the absence ofTCR (50) . Although it is not known whether murine CD2 transmits activation signals, the fact that both murine and human CD2 are highly homologous and share a long cytoplasmic tail suggests that murine CD2 has a similar role in B cell activation (50, 51) . In this respect, CD2 on murine B cells may also couple with signal transduction elements on Fcy receptors or membrane immunoglobulins . The recent demonstration that the B cell antigen receptor of the IgM class is noncovalently associated with another subunit termed mb-1 (52) , which has a cytoplasmic tail consisting ofa motif shared between CD3 subunits and FceRIy (48, 53) (as described below), suggests that mb-1 may couple functionally to murine CD2 on B cells.
The FceRIy subunit of FceRI also appears to be a component of murine FcyRIII (26) and human FcyRIII (CD16) (24) , and bears significant homology to CD3'/q (36, 47, 48) . The localization of FceRIy and CD3"/r7 subunit genes to mouse chromosome 1 (27, 28) , their similar genomic and structural organization, and the sequence homologies between exon 2 encoding the transmembrane region of both genes and between the last two exons of the cytoplasmic domains suggest that they belong to a new family of genes that play a significant role in signal transduction (36, 47) . The functional relevance of the primary sequence homology between CD3' and the FceRIy subunit has been provided by a recent experiment in Xenopus oocytes showing that CD3" can substitute for FceRIy in the assembly and surface expression of FceRI (54) . Moreover, a conserved amino acid motif (D [or EjxxYxxLxxxxxxxYxxL [orI] ) is present in the cytoplasmic domains of receptor molecules such as FceRIy, CD3', CD3,q, and mb-1 (48 [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] ) would be expected to lie on the same side of an a-helical barrel if the cytoplasmic sequence formed an a helix. As such, the residues could form a binding site for putative proteins involved in the generation ofsignals after receptor crosslinking. Therefore, it is possible that the FceRIy subunit shared between murine FceRI and FcyRIII is involved in coupling with the CD2-mediated signal transduction pathway in MC/64.1 cells . It seems likely that the TCRindependent CD2 signalling machinery is linked to the FceRIy, CD3', and/or CD371 and mb-1 subunits in some cells such as CD3 -NK cells, thymocytes, and murine B cells. Further analysis, including reconstitution of CD2-mediated signal transduction in TCR -Jurkat variants by transfection with CD16 or other Fc receptors, could provide additional evidence for this hypothesis.
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